Retinoblastoma in a 23-year-old adult treated with primary intra-arterial and intravitreal chemotherapy

Intra-arterial chemotherapy (IAC) continues to provide a globe-sparing alternative as primary treatment for retinoblastoma with few adverse events. While there is growing evidence to highlight the utility of IAC in children with retinoblastoma, adult cases treated with primary IAC have not previousl...

Descripción completa

Detalles Bibliográficos
Autores principales: McMahon, Jeffrey F., Jabbour, Pascal, Shields, Carol L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561044/
https://www.ncbi.nlm.nih.gov/pubmed/31198299
http://dx.doi.org/10.4103/ojo.OJO_162_2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561044/
https://www.ncbi.nlm.nih.gov/pubmed/31198299
http://dx.doi.org/10.4103/ojo.OJO_162_2018

Ejemplares similares